ATE373828T1 - Verfahren zur quantifizierung der blutplättchenaktivierung - Google Patents

Verfahren zur quantifizierung der blutplättchenaktivierung

Info

Publication number
ATE373828T1
ATE373828T1 AT99933539T AT99933539T ATE373828T1 AT E373828 T1 ATE373828 T1 AT E373828T1 AT 99933539 T AT99933539 T AT 99933539T AT 99933539 T AT99933539 T AT 99933539T AT E373828 T1 ATE373828 T1 AT E373828T1
Authority
AT
Austria
Prior art keywords
platelet activation
platelets
quantifying
provides
present
Prior art date
Application number
AT99933539T
Other languages
English (en)
Inventor
David Schneider
Burton Sobel
Paula Tracy
Paul Held
Paul Hale
Norman Alpert
Original Assignee
Lionheart Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lionheart Technologies Inc filed Critical Lionheart Technologies Inc
Application granted granted Critical
Publication of ATE373828T1 publication Critical patent/ATE373828T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/7056Selectin superfamily, e.g. LAM-1, GlyCAM, ELAM-1, PADGEM
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745Assays involving non-enzymic blood coagulation factors
    • G01N2333/75Fibrin; Fibrinogen
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/971Capture of complex after antigen-antibody reaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AT99933539T 1998-07-15 1999-07-02 Verfahren zur quantifizierung der blutplättchenaktivierung ATE373828T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/115,992 US6391568B1 (en) 1998-07-15 1998-07-15 Method for determining platelet reactivity in a whole blood sample

Publications (1)

Publication Number Publication Date
ATE373828T1 true ATE373828T1 (de) 2007-10-15

Family

ID=22364609

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99933539T ATE373828T1 (de) 1998-07-15 1999-07-02 Verfahren zur quantifizierung der blutplättchenaktivierung

Country Status (5)

Country Link
US (1) US6391568B1 (de)
EP (1) EP1095280B1 (de)
AT (1) ATE373828T1 (de)
DE (1) DE69937146T2 (de)
WO (1) WO2000004388A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221672B1 (en) * 1996-04-30 2001-04-24 Medtronic, Inc. Method for determining platelet inhibitor response
GB9901504D0 (en) * 1999-01-22 1999-03-17 Gray Charles R W Accelrrated whole blood clotting time (A.W.B.C.T.)
DE60118362T2 (de) * 2000-05-19 2007-05-24 The Center for Blood Research, Inc., Boston VERFAHREN ZUR BEHANDLUNG VON HÄMOSTATISCHEN STÖRUNGEN DURCH LöSLICHES P-SELECTIN
US6913932B2 (en) * 2002-08-23 2005-07-05 Beckman Coulter, Inc. Formaldehyde-ammonium salt complexes for the stabilization of blood cells
JP2005538383A (ja) * 2002-09-10 2005-12-15 プラコア・インコーポレーテッド 血小板機能を監視する方法および装置
US7071001B2 (en) 2003-01-10 2006-07-04 Dnk Associates, Inc. System and method for in vitro bleeding time testing
US7422905B2 (en) * 2004-02-27 2008-09-09 Medtronic, Inc. Blood coagulation test cartridge, system, and method
US7439069B2 (en) * 2004-02-27 2008-10-21 Nippoldt Douglas D Blood coagulation test cartridge, system, and method
US7399637B2 (en) * 2004-04-19 2008-07-15 Medtronic, Inc. Blood coagulation test cartridge, system, and method
EP1875232A2 (de) * 2005-04-25 2008-01-09 PlaCor, Inc. Verfahren und vorrichtungen zur überwachung der blutplättchenfunktion
RU2432577C2 (ru) * 2005-10-18 2011-10-27 Фудзимори Когио Ко., Лтд. Устройство мониторинга образования тромба и способ мониторинга образования тромба
AU2006305163B2 (en) 2005-10-18 2012-09-27 Fujimori Kogyo Co., Ltd. Apparatus for monitoring thrombus formation and method of monitoring thrombus formation
EP1890155A1 (de) * 2006-08-17 2008-02-20 F. Hoffmann-Roche AG Verfahren und Vorrichtungen zur Bestimmung der Blutplättchenfunktion und zur Diagnose von Blutplättchen-bedingten und kardiovaskulären Erkrankungen
US20100099130A1 (en) * 2006-10-25 2010-04-22 Placor Inc. Methods and devices for monitoring platelet function
EP2352025B1 (de) * 2008-08-11 2020-07-15 Fujimori Kogyo Co., Ltd. Thrombozytentestverfahren
FR2945126B1 (fr) * 2009-04-29 2019-11-01 Commissariat A L'energie Atomique Procede et appareil de comptage des thrombocytes
WO2015054662A1 (en) 2013-10-10 2015-04-16 Eastern Virginia Medical School 4-((2-hydroxy-3-methoxybenzyl)amino) benzenesulfonamide derivatives as 12-lipoxygenase inhibitors
EP3700419A4 (de) * 2017-10-26 2021-11-10 Essenlix Corporation Schnelltest von blutplättchen
JP2021501321A (ja) 2017-10-26 2021-01-14 エッセンリックス コーポレーション 組織および細胞染色のためのデバイスおよび方法
US12235278B2 (en) 2018-08-24 2025-02-25 Beth Israel Deaconess Medical Center, Inc. Compositions and methods for evaluation of antiplatelet drug sensitivity
WO2022136959A1 (en) * 2020-12-21 2022-06-30 Sedicidodici S.R.L. Method for evaluating blood parameters
CN115792222B (zh) * 2022-12-29 2025-08-05 北京乐普诊断科技股份有限公司 一种血小板p2y12受体抑制率的免疫层析检测试剂盒和制备方法及检测方法
CN115902203B (zh) * 2023-01-03 2025-07-11 北京乐普诊断科技股份有限公司 血小板GP IIb/IIIa受体抑制率的免疫层析检测试剂盒和制备方法及检测方法
CN116840485B (zh) * 2023-05-18 2025-03-14 河络新图生物科技(上海)有限公司 一种检测血小板功能亚群PAC-1标志物、Annexin-V标志物和CD62P标志物的检测系统、检测方法及检测试剂盒

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8631084D0 (en) 1986-12-31 1987-02-04 Amersham Int Plc Shutter assembly
NZ235778A (en) 1989-10-25 1992-11-25 Russell M Jaffe Enzyme assay and assay kit to measure cellular activation
CA2144180A1 (en) * 1992-09-08 1994-03-17 George A. Heavner Peptide inhibitors of cellular adhesion
WO1994013307A1 (en) 1992-12-11 1994-06-23 Steritech, Inc. Platelet activation and function
AU1128195A (en) 1993-10-26 1995-05-22 Mayo Foundation For Medical Education And Research Direct fluorescence-conjugated immunoassay for platelet activation
ATE202942T1 (de) * 1994-04-15 2001-07-15 Cobe Cardiovascular Inc Blutverträglicher beschichteter artikel

Also Published As

Publication number Publication date
DE69937146T2 (de) 2008-08-28
DE69937146D1 (de) 2007-10-31
US6391568B1 (en) 2002-05-21
WO2000004388A2 (en) 2000-01-27
EP1095280A2 (de) 2001-05-02
WO2000004388A3 (en) 2000-06-29
EP1095280B1 (de) 2007-09-19

Similar Documents

Publication Publication Date Title
ATE373828T1 (de) Verfahren zur quantifizierung der blutplättchenaktivierung
ATE246356T1 (de) Vorrichtung zum vorhersagen von physiologischen messwerten
ATE164943T1 (de) Verfahren und vorrichtung zur bewertung der fitness von biopolymeren
DE60014348D1 (de) Messung und verwendung von molekularen wechselwirkungen
DK1077634T3 (da) Monitorering af fysiologiske analytter
ATE250143T1 (de) Verfahren und vorrichtung zum nachweis und zur quantifizierung von biomolekülen
ATE278805T1 (de) Verfahren zur quantifizierung von cholesterol in lipoproteinen und quantifizierungsreagenzien
ATE278803T1 (de) Verfahren zur überwachung der proteasomeinhibitorarzneimitteleffekte
BG104275A (en) Method and device for express analysis of tested parameters in biological samples
ATE386934T1 (de) Methode und vorrichtung zum nachweis oder zur quantifizierung von kohlenhydrate enthaltenden verbindungen
DE60006975T2 (de) Analytische testvorrichtung mit orientierte durchgehende kanäle besitzendem substrat und verbessertes verfahren und vorrichtung zum gebrauch derselben
ATE353138T1 (de) Verfahren zur stabilisierung und messung von troponinkomplexen
ATE371189T1 (de) Liganden-bindetest und kit mit einer abtrennzone für störende probenkomponenten
DE59504495D1 (de) Verfahren und vorrichtung zur analyse von glucose in einer biologischen probe
DE69418546D1 (de) Vorrichtung und Verfahren zur Messung der Konzentration von Glukose mittels Lichtstreuung
DK0502928T3 (da) Fremgangsmåder til detektion af collagennedbrydning in vivo
ATE205884T1 (de) Assays und vorrichtungen zum nachweis von extrahepatischer biliäreratresie
ES532954A0 (es) Un dispositivo de ensayo para determinar la presencia de una sustancia en una muestra a ensayar
DE60015726D1 (de) Verfahren und vorrichtung zum vorhersagen von haemostatischer funktionsstörung in patientenproben
ATE510209T1 (de) Verfahren und vorrichtung zur messung von lipidperoxidation in biologischen flüssigkeiten und stuffsuspensionen
ATE173830T1 (de) Verfahren zur bestimmung der quantität extrazellulärer bpi in körperflüssigkeiten
NO20011353L (no) Cobalamin-måling
CY1106705T1 (el) Δοκιμασια για μετρηση ολο-τρανσκοβαλαμινης και φολικου
DE69530613D1 (de) Verfahren zur Messung der Silber- oder Halogenionenkonzentration und Vorrichtung dafür
DE59910326D1 (de) Verwendung derivatisierter Reagenzien in Chemilumineszenz- und Elektrochemilumineszenz-Nachweisverfahren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties